Young breast cancer patients are more likely to have higher-grade, triple-negative and HER2-positive tumors than older women (Azim et al., 2012; Azim and Partridge, 2014; Rosenberg et al., 2015). This evidence concerns the gene ERBB2 and breast cancer.